Sitemap - 2023 - Protons 101
Proton Therapy: "Study of the Year" Edition
SBRT: Progress in Pancreatic Cancer!
Prostate Cancer: Add Chemo? No thank you.
Massive Benefit using Radiation in Metastatic Disease!!
The World According to Timmerman...
SBRT: Renal Cell Cancer. 100% control rate
A Radiation Payment Model Discussion
Intermediate Risk Prostate Cancer: How good is good enough?
How do we value our own technology?
PACE B: 95% Cure Rate at 5 yrs!!
ASTRO 2023: A Quick View from the Road
High Risk Prostate Cancer: Beyond FLAME and PRIME
Biochemical Recurrence: Does it even matter?
Protons for Prostate Cancer: 2772 patients! Outstanding results in a retrospective setting.
A Major Synergistic Win In Lung Cancer!! High Dose Radiation Plus Immunotherapy:
Randomized Prospective Trial Demonstrates Proton Therapy Outperforms TACE in Liver Cancer
PPS and Protons!! The ROCR Exemptions...
ROCR: ASTRO's New Payment Direction
AI enters the Prostate Landscape: Part 2
AI Enters the Landscape of Prostate Cancer
Mentally, I file this as "Over Cooked"
A Glimpse Behind the Curtain: ViewRay
PSA Kinetics - Even we get confused.
Why we require randomized data for protons.
Ongoing European Randomized Proton Trials (REFERENCE SERIES)
High Risk Prostate Cancer: A Complex Landscape, but with Strong Ongoing Trials
Protons 101: A Summary of the More Business Slanted Posts and one on ChatGPT just cause :)
Prostate Cancer: We begin the dive into higher risk disease
Protons 101: That money / cost thing
How do we compete within a framework of massive financial imbalances?
Prostate Cancer: The Embark Trial
Head and Neck Cancer Radiation: The Risk of De-Escalation - When is it a bridge too far?
RTOG 0815: Dose Escalation and ADT. Questions answered?
Prostate SBRT: 92%+ Control. Prospective Multi-institutional data
RAPIDO Rectal Cancer Trial: Another Example Where EQD2 Dose Matters
Esophageal Cancer Awareness Month: The argument for Proton Therapy (ADVOCACY SERIES)
ChatGPT: It crushed doctors on patient questions, so can it replace Protons101?
Prostate Cancer: A Tale of 20 yrs: Standards...
Prostate Cancer: SBRT Journey Part 3: Questions, Outcomes, Trials, and New Metrics
Breast Cancer: Just add Lidocaine?
Prostate Cancer: An SBRT Journey: Part 2: Intermediate Risk Outcome Data
Prostate cancer: An SBRT Journey: Part 1: The Backdrop
Breast Cancer, Radiation, and Heart Health: (PATIENT ADVOCACY SERIES)
Prostate Cancer: Using 1yr and 2yr PSA Metrics to Improve Outcomes and Limit ADT
ProtecT: 15 yr results! Great science! But does it translate to the US?
Prostate Cancer Radiotherapy - Can We De-Escalate "Better"? (REFERENCE SERIES)
ASTRO Workforce Analysis: Pressures Unique to our field
Non-inferiority Trial Design (REFERENCE SERIES)
Protons 101: Head and Neck Proton Trial Landscape: Europe to the rescue!!
Protons 101: Radiation Oncology OAR metrics: Which is the strongest?
Protons 101: The Accelerator Podcast
Protons 101: The COMPARRE Trial - Proton vs. IMRT for Prostate Cancer
OAR metrics demonstrating correlation to clinical outcomes (REFERENCE SERIES)
Protons 101: A path to greater impact - refocus on cancer outcomes and embrace technology.
Review of Prospective Randomized IMRT clinical data as of 2023 (REFERENCE SERIES)
Protons 101: A recent randomized study of rectal spacing.
Protons 101: The Opportunity for Protons to Improve Outcomes in Breast Cancer
Protons 101: What could/should a proton look like? Intro to the PRODOSC Trial
Protons 101: Two new technology trials are on the horizon in radiation oncology for pancreas cancer.
Protons 101: What happened to rectal spacer benefit in the MRI MIRAGE Trial?
Protons 101: Was the MIRAGE MRI Prostate Cancer Trial Positive?
The Opportunity for Protons in Head and Neck Cancer.
Proton Therapy vs. IMRT for Head and Neck Cancer: A look back